What is Myriad Genetics's change in AP?

Myriad Genetics (MYGN) reported change in AP of $5.4M in Q1 2026.

What is the long-term trend for Myriad Genetics's change in AP?

Over 2 years (2021 to 2025), Myriad Genetics's change in AP has grown at a -61.0% compound annual growth rate (CAGR), from $9.2M to -$1.4M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Myriad Genetics MYGN Change in AP

Change in AP at other companies

Labcorp HoldingsLH

-$138.7M+6.0%

Quest DiagnosticsDGX

-$12M+77.4%

NeoGenomicsNEO

$718K-37.2%

VeracyteVCYT

$2.59M-63.7%

Natera, Inc.NTRA

$21.88M+820%

Fulgent Genetics, Inc.FLGT

-$408K+38.0%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's change in AP?: Myriad Genetics (MYGN) reported change in AP of $5.4M in Q1 2026.
What is the long-term trend for Myriad Genetics's change in AP?: Over 2 years (2021 to 2025), Myriad Genetics's change in AP has grown at a -61.0% compound annual growth rate (CAGR), from $9.2M to -$1.4M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.